SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales moved up 41.62% to Rs. 12781.88 millions for the March 2025 quarter as compared to Rs. 9025.46 millions during the year-ago period.The Net Profit of the company reported a remarkable increase of 381.60% to Rs. 1395.57  millions  from Rs. 289.78 millions in previous same quarter.Operating Profit saw a handsome growth to 2670.33 millions from 1404.71 millions in the quarter ended March 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 12781.88 9025.46 41.62 43819.24 34976.55 25.28 43819.24 34976.55 25.28
Other Income 223.96 406.10 -44.85 1188.07 1262.36 -5.89 1188.07 1262.36 -5.89
PBIDT 2670.33 1404.71 90.10 7656.44 5801.51 31.97 7656.44 5801.51 31.97
Interest 240.69 394.64 -39.01 1129.62 1660.92 -31.99 1129.62 1660.92 -31.99
PBDT 2429.64 916.92 164.98 6526.82 4047.44 61.26 6526.82 4047.44 61.26
Depreciation 569.12 562.19 1.23 2249.72 2048.32 9.83 2249.72 2048.32 9.83
PBT 1860.52 354.73 424.49 4277.10 1999.12 113.95 4277.10 1999.12 113.95
TAX 464.95 64.95 615.86 1105.82 390.78 182.98 1105.82 390.78 182.98
Deferred Tax -170.95 0.89 -19307.87 -21.25 4.97 -527.57 -21.25 4.97 -527.57
PAT 1395.57 289.78 381.60 3171.28 1608.34 97.18 3171.28 1608.34 97.18
Equity 1894.83 1811.52 4.60 1894.83 1811.52 4.60 1894.83 1811.52 4.60
PBIDTM(%) 20.89 15.56 34.23 17.47 16.59 5.34 17.47 16.59 5.34

Emcure Pharma Share Price

1678.50 36.90 (2.25%)
11-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1872.40
Dr. Reddys Lab 1279.70
Cipla 1304.70
Zydus Lifesciences 956.65
Lupin 2245.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×